ストックスクリーナーアプリを入手
77.91
0.36%
-0.3581
前日終値:
$78.27
開ける：
$78.51
24時間の取引高:
2.19M
Relative Volume:
0.40
時価総額：
$32.66B
収益：
$9.51B
当期純損益:
$2.64B
株価収益率:
12.91
EPS:
6.0361
ネットキャッシュフロー:
$2.14B
1週間 パフォーマンス:
-4.09%
1か月 パフォーマンス:
-31.49%
6か月 パフォーマンス:
-39.16%
1年 パフォーマンス:
-53.34%
1日の値動き範囲:
$77.47
$78.88
1週間の範囲:
$77.47
$81.31
52週間の値動き範囲:
$72.38
$172.23
Zoetis Inc Stock (ZTS) Company Profile
Compare ZTS vs TAK, TEVA, HLN, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ZTS
Zoetis Inc
|
77.91 | 32.81B | 9.51B | 2.64B | 2.14B | 6.0361 |
TAK
Takeda Pharmaceutical Co Adr
|
15.99 | 51.03B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.78 | 40.20B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.121 | 40.78B | 14.54B | 2.22B | 2.58B | 0.4871 |
UTHR
United Therapeutics Corp
|
550.88 | 23.86B | 3.17B | 1.29B | 1.01B | 27.09 |
Zoetis Inc Stock (ZTS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-15 | 開始されました | Citigroup | Buy |
| 2026-01-22 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2025-12-15 | ダウングレード | BofA Securities | Buy → Neutral |
| 2025-12-09 | 開始されました | Barclays | Equal Weight |
| 2025-11-21 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2025-07-17 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2025-06-18 | ダウングレード | Stifel | Buy → Hold |
| 2024-12-02 | 開始されました | Leerink Partners | Outperform |
| 2024-07-25 | 開始されました | BTIG Research | Buy |
| 2024-01-12 | 繰り返されました | Stifel | Buy |
| 2023-12-19 | 再開されました | Jefferies | Buy |
| 2023-12-07 | 開始されました | Exane BNP Paribas | Outperform |
| 2023-09-06 | 開始されました | HSBC Securities | Buy |
| 2022-07-12 | 開始されました | Piper Sandler | Overweight |
| 2021-11-18 | 開始されました | Morgan Stanley | Overweight |
| 2021-08-05 | 再開されました | Credit Suisse | Outperform |
| 2021-07-16 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2021-03-08 | アップグレード | BofA Securities | Neutral → Buy |
| 2021-03-08 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2020-09-21 | 開始されました | Atlantic Equities | Overweight |
| 2020-08-14 | アップグレード | Edward Jones | Hold → Buy |
| 2020-08-12 | ダウングレード | Gabelli & Co | Buy → Hold |
| 2020-05-27 | 開始されました | Jefferies | Buy |
| 2020-01-10 | 開始されました | Raymond James | Mkt Perform |
| 2019-09-09 | 開始されました | Goldman | Buy |
| 2019-07-01 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2019-06-11 | 開始されました | Barclays | Overweight |
| 2019-05-23 | 開始されました | Guggenheim | Buy |
| 2019-05-03 | ダウングレード | Gabelli & Co | Buy → Hold |
| 2019-03-20 | 開始されました | SunTrust | Hold |
| 2019-03-04 | アップグレード | Stifel | Hold → Buy |
| 2019-01-23 | 開始されました | UBS | Neutral |
| 2018-10-15 | アップグレード | JP Morgan | Neutral → Overweight |
| 2018-08-22 | ダウングレード | Stifel | Buy → Hold |
| 2018-08-03 | 繰り返されました | Stifel | Buy |
| 2018-04-19 | 繰り返されました | Citigroup | Buy |
| 2018-03-19 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2018-02-16 | 繰り返されました | Stifel | Buy |
| 2018-01-04 | アップグレード | Citigroup | Neutral → Buy |
すべてを表示
Zoetis Inc (ZTS) 最新ニュース
Bronstein, Gewirtz & Grossman, LLC Encourages Zoetis, Inc. (ZTS) - The National Law Review
ZOETIS INC. (ZTS) INVESTOR ALERT Investors With Large - GlobeNewswire
ZTS Investors Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit with the Schall Law Firm - The Daily Tribune News
ZTS Investors Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit - PR Newswire
Zoetis Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Rosen Law Firm Urges Zoetis Inc. (NYSE: ZTS) Stockholders to Contact the Firm for Information About Their Rights - The Joplin Globe
Class action lawsuit filed against Zoetis over ... | Pluang – Crypto, Stocks, Gold & Funds - Pluang
FinancialContentLaw Offices of Howard G. Smith Encourages Zoetis Inc. (ZTS) Shareholders To Inquire About Securities Fraud Class Action - FinancialContent
Class action filed against Zoetis over alleged misleading statements on product growth and market share. - Pluang
Bronstein, Gewirtz & Grossman LLC Urges Zoetis Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire
ZTS INVESTOR ALERT: Zoetis Inc. Investors with Substantial Losses Have Opportunity to Lead the Zoetis Class Action Lawsuit – Company AnnouncementFT.com - Financial Times
Zoetis faces class action over alleged misleading claims on key animal health products. - Pluang
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zoetis Inc.ZTS - PR Newswire
ZTS Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Zoetis Inc. - PR Newswire
Zoetis Stock Testing Price Floor – Buy Now? - Trefis
Argus Research downgrades Zoetis (ZTS) - MSN
Investor Notice: Robbins LLP Informs Investors of the Zoetis Inc. Class Action - The National Law Review
Behavioral Patterns of ZTS and Institutional Flows - Stock Traders Daily
Zoetis Investor Sues Over Dog Medicines’ Market Competitiveness - news.bloombergtax.com
Labaton Keller Sucharow LLP Files Securities Class Action Against Zoetis, Inc. and Certain of Its Executives - Business Wire
ZTS Downgraded by Argus Research -- Rating Changed to Hold - GuruFocus
Zoetis (ZTS) Securities Fraud InvestigationLevi & Korsinsky - Morningstar
Argus downgrades Zoetis stock rating on competition, margin pressure - Investing.com
Argus downgrades Zoetis stock rating on competition, margin pressure By Investing.com - Investing.com Canada
Argus Downgrades Zoetis to Hold From Buy - marketscreener.com
Assessing Zoetis (ZTS) Valuation After Steep Share Price Weakness And Profitability Concerns - simplywall.st
Zoetis, Inc. (ZTS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Zoetis, Inc. (ZTS) Investigation: Bronstein, Gewirtz & Grossman - The National Law Review
Zoetis faces investor lawsuit after Q1 profit guidance cut and 21.5% stock drop. - Pluang
ZTSZoetis Inc Stock Price and Quote - Finviz
Zoetis Inc. stock outperforms competitors despite losses on the day - MarketWatch
Bronstein, Gewirtz & Grossman, LLC Is Investigating Zoetis, Inc. (ZTS) And Encourages Investors to Connect - ACCESS Newswire
ZTS Technical Analysis | Trend, Signals & Chart Patterns | ZOETIS INC (NYSE:ZTS) - ChartMill
Zoetis Inc. (ZTS) Stock Analysis: Exploring a 53% Potential Upside in the Animal Health Leader - DirectorsTalk Interviews
Bronstein, Gewirtz & Grossman, LLC Encourages Zoetis, Inc. (ZTS) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Zoetis Stock Rockets 9.6% With 5-Day Winning Streak - Trefis
Zoetis elects directors and reports shareholder votes at annual meeting By Investing.com - Investing.com Nigeria
Zoetis Stock 5-Day Winning Spree: Stock Climbs 9.6% - Trefis
Securities Fraud Investigation Into Zoetis Inc. (ZTS) Continues – - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Encourages Zoetis, Inc. (ZTS) Investors to Inquire about Securities Investigation - ACCESS Newswire
Zoetis Inc. (ZTS) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation - The Norfolk Daily News
Zoetis Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Securities Fraud Investigation Into Zoetis Inc. (ZTS) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - Business Wire
Zoetis Inc. Files Form 8-K Reporting Annual Meeting Results and Shareholder Votes – May 2026 - Minichart
Stifel cuts Zoetis stock price target on competitive pressures By Investing.com - Investing.com South Africa
Stifel Maintains Zoetis(ZTS.US) With Hold Rating, Cuts Target Price to $95 - Moomoo
Stifel cuts Zoetis stock price target on competitive pressures - Investing.com
Zoetis elects directors and reports shareholder votes at annual meeting - Investing.com
Zoetis Faces Fraud Probe As Burry Backs Dividend-Paying Animal Health Firm - Sahm
Declaration of Voting Results by Zoetis Inc - marketscreener.com
ZTS News | ZOETIS INC (NYSE:ZTS) - ChartMill
Zoetis Inc (ZTS) 財務データ
収益
当期純利益
現金流量
EPS
0.65%
0.71%
大文字化:
|
ボリューム (24 時間):